Shorepoint Capital Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$4.84M Buy
2025
Q1
$5.25M Buy
2024
Q4
$6.13M Buy
2024
Q3
$8.43M Sell
2024
Q2
$10.2M Sell
2024
Q1
$9.39M Sell
2023
Q4
$8.21M Sell
2023
Q3
$7.48M Sell
2023
Q2
$7.6M Buy
2023
Q1
$7.27M Buy
2022
Q4
$5.92M Buy